p.01/....
|
|
- きゅうた ふじた
- 7 years ago
- Views:
Transcription
1 1990Dr. Sackett EBMEvidence-Based Medicine EBMEBM DI EBMDI DI 2 Vol. 22 No
2 Evidence-Based Drug InformationEBDI EBDI IF IF EBDI EBDI EBDI EBDI Vol. 22 No
3 Y2K Celera GenomicsCelera Celera Incyte Pharmaceuticals National Institute of Health Department of Energy Human Genome Project Celera Whitehead Institute for Biomedical Research Genome Sequencing Center at the Washington UniversityBaylor College of MedicineJoint Genome Institute Sanger Centre Vol. 22 No
4 Celera Human Genome Sciences6700 SNP Consortium, Ltd Expressed Sequence TagsESTs Single Nucleotide PolymorphismsSNPs SNPs The SNP Consortium, LtdTSC Wellcome Trust TSC Astra ZenecaBayerBristol-Myers Squibb Hoffmann-La RocheGlaxo-WellcomeHoechst Marion RousselMotorolaNorvatisPfizer SearleSmithKline Beecham Whitehead Institute for Biochemical ResearchWashington University s Genome Sequence CenterWellcome Trust s Sanger CentreStanford Human Genome CenterCold Spring Harbor Laboratory 1123SNP 2566SNPs TSC SNPs15 URL Vol. 22 No
5 6 Vol. 22 No ftp://ftp.sanger.ac.uk/pub/human/sequences ftp://genome.wustl.edu/pub/gsc Sanger Centre SNPs [(3)] 21 [(4)] 2001 cdna SNPs cdna
6 7 Vol. 22 No hierachy a RNA Rational Drug Design Combinatorial Chemistry High-Throughput Screening Pharmacogenomics SNPs DNA DNA SNPs
7 genotype P450CYPCYP2D CYP2D6 CYP2D6 tacrinehcl apolipoproteine E3 25E4 E4 HMG-CoA pravastatin sodium cholesterol ester transport proteinb2 B1 SNPs 21 tailor-made or personalized medicine 8 Vol. 22 No
8 9 Vol. 22 No SNPs b SNPs Polymerase Chain ReactionPCRDNA DNA CVD35 CVD35 E PCR
9 10 Vol. 22 No
10 13 Vol. 22 No
11 Q & A Vol. 22 No
12 15 Vol. 22 No Heinrich Biirger
13 16 Vol. 22 No
14 17 Vol. 22 No
15 18 Vol. 22 No
16 19 Vol. 22 No history/history3/history3.html.
17 Vol. 22 No
18 Vol. 22 No
19 23 Vol. 22 No plastic bronchitis
20 (2000),, plastic bronchitis (1994) 24 Vol. 22 No
21 Vol. 22 No
22 ;; ;;; yyy ;; ;; ;; 26 Vol. 22 No
23 27 Vol. 22 No
24 Vol. 22 No
25 29 Vol. 22 No USP-DI 300 TIP 80 abc de fg
26 H.S Vol. 22 No
27 31 Vol. 22 No a b b1 b2 b3 b4
28 32 Vol. 22 No H.S
29 cm81cm Vol. 22 No
30 34 Vol. 22 No lex salica
31 ha Linum linon usitatissimum usitatas Flax Common flax, flax, Dreschlein, Flachs, Klenglein lin cultivé m cm cm perennial flax lin vivace cm 1.5 cm cm Stellera 5060cm Vol. 22 No
32 cm 3.5mm mm linoleic acid linolenic acidoleic acid stearic acidpalmitic acid glogulin pentosan linamarin 4.5g pentosan g 36 Vol. 22 No
33 lynoxyn Linen Vol. 22 No
34 39 Vol. 22 No Vol.22 No.5 GHQ
35 Vol. 22 No
36 Vol. 22 No
37 t1/2 mg Vol. 22 No
38 tmax t1/ Vol. 22 No
39 DI REPORT 10 HIV DI 1981AIDS AIDS LAVHTLV-ARV 1986 HIV AIDS HIVHIV2 HIVHIV1 HIV2HIV1 HIV 120nm HIV HIV PAEIAHIV WB HIV HIV HIVHIV window periodsilent AIDS HIV HIVp24HIV gag PCRPCR PAparticle agglutination HIV HIV HIV EIAenzyme immunoassay ELISAEnzyme-linked immunosorbent assay EIA HIV Vol. 22 No
40 DI REPORT HIV HIV CLEIAchemiluminescent enzyme immunoassay EIA WBwestern blot immunoblotting method HIV SDSPAGE HIV1 Immunochromatography Assay HIV HIVHIV HIV HIV HIVHIV HIV PCRpolymerase chain reaction HIVDNA HIVCD4 HIVRNA DNADNA CD4DNA RNA CD4PCR DNA chain reaction HIVDNA RTPCRreverse transcription polymerase chain reaction HIVRNA HIVRNA HIVRNA HIV Vol.53No Vol.51No ABC AIDSATL HIV 46 Vol. 22 No
41 DI REPORT HIV12 PA HIV1 HIV HIV1 HIV ,000 H118 HIV12 PA PA HIV1 HIV , ,000 H72 HIV12 EIA HIV1 HIV ,000 H101 HIV1HIV2 EIA HIV1 HIV2 AxSYM 28 1 HIV HIV ,000 [] 4 230ml 45,000 H91 HIV1HIV2EIA PLUS EIA HIV1 HIV HIVHIV HIV OPDOPD ,000 AIDSAIDS H87 AntiHIV12 EIA HIV1 HIV POD ,400 HIV10 H86 HIV12 CLEIA HIV1 HIV HIV ,000 AMPPD 100ml6 150, ml6 30, ml4 64,000 H93 Vol. 22 No
42 DI REPORT HIV HIV 12 WB HIV WB HIV WB HIV1HIV WB HIV 28 4 HIV 1HIV HIV HIV12HIV HIV 63 72, , , , ,500 HIV1 H37 HIV2 H36 WB HIV12 HIV 1HIV2 H36 WBEIA AIDS HIV HIV H2 H Vol. 22 No
43 DI REPORT HIVEIA EIA HIV HIV p HIVIgG HIV OPDOPD 1N ,000 H411 HIV1 PCR HIV1DNA 28 HIV 6 PN HIV DNA 10 HIV ,000 HIV ,000 HIV1DNA H64 HIV1 RT PCR HIV1 RNA 28 6 HIV1 QS HRP A B ,000 HIV HIV H93 HIV EIA HIV1 OHIV2 HIVp HIV4HIV4 HIV4C1 HIV4C2HIV4 S ,000 HIV1HIV2 HIVp24 HIV H Vol. 22 No
44 ddddddddddddddddddddddddddddddddddddddddddddd ddddddddddddddddddddddddddddddddddddddddddddd TB Vol. 22 No
45 B 97 BT 52 Vol. 22 No
46 97T Vol. 22 No
47 T T 54 Vol. 22 No
48 Vol. 22 No
49 56 Vol. 22 No
50 Vol. 22 No
51 immunolgobulin YFcIgGIgAIgMIgDIgE IgE T IgE IgG IgG MHC MHC T 58 Vol. 22 No
52 59 Vol. 22 No MHC T T Y!!! 12TTTh1 12 BIgG T TTTh B
53 TNF CDcluster of differentiation CD4TCD8T CD CD86TCD28 CD160 97T TMHC TMHCT TT B BY IIMHC 60 Vol. 22 No
54 BB MHCTT AIDS, CD, Ig, MHC, TNF AIDS acquired immunodeficiency syndrome CD cluster of differentiation Ig immunogloblin MHC major histocompatibility complex TNF tumor necrosis factor Vol.21 No.8 Vol.22 No.2 Vol.21 No.9 Vol.22 No.3 Vol.21 No.10 TDNA Vol.21 No.11 Vol.22 No.4 10Vol.22 No.5 Vol.21 No.12 11Vol.22 No.6 Vol.22 No.1 12Vol.22 No.7 Vol. 22 No
55 62 Vol. 22 No
56 , ,000 aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa FAX FAX Vol. 22 No
57 64 Vol. 22 No ,,
58 PI , ,938 vu , ,555,333 1,394,932 24,160,401 Vol. 22 No
59 /1018 / A 21 Topic http// 66 Vol. 22 No
›Ê”÷„¤‰ƒ‘−…j…–†[…X
ISSN 1347-0345 National Institute of Fruit Tree Science 2003. 10 2 2003. 10 3 19761986 1989 5219 1997 19 12 10 250 270g Brix 15 160.5g/100ml 1590 10 2003. 10 4 DNA DNASSR 44 41SSR SSR Simple Sequence Repeat=
More information免疫Ⅱ
100 100 100 1990 127 DNA DNA DNA DNA hybridization DNA RNA DNA DNA 128 12 µδγαε 129 300 1,200 500 50012 4 24,000 1,20024,000 2.910 7 10 8 rejection major histocompatibility complex MHC MHC MHC 130 MHC
More information無印良品 2012 自転車 カタログ
26 897895321,000 140cm 76.0cm 16.0kg H LED 3 263 897896025,000 140cm 76.0cm 16.5kg H 3 LED 20 8978984 8978977 19,800 134cm 73.0cm 15.0kg LED 2620 2620 8486656550 5536207483 14512372,100 8279999840 26 77342561,417
More informationKey words: HIV screening kit, window period, p24antigen, enzyme-linked fluorescent assay
Key words: HIV screening kit, window period, p24antigen, enzyme-linked fluorescent assay Fig.1 @ A principle of assay The assay comprises of two reactions. The first reaction, for the detection of anti-hiv-
More informationMHC23-3
Major Histocompatibility Complex 2016; 23 (3): 168 184 1) 2) 3) 4) 5) 1) 6) 7) 8) 1) 2) 3) 4) HLA 5) 6) 7) 8) HLA 11 25 28 10 22 1 4 61 44 6 1 10 11 5 HLA 60 3 27 3 5 9 5 10 19 5 50 22.4 5.9 8.2% 78.7%
More information(2) (2) (3) (3) (4) ABI PRISM 7700 TaqMan (4) Roche LightCycler TM (5) BioFlux LineGene TaqMan (6) 1 RT-PCR (7) (9) (10) F. Hoffmann-La Roche Ltd. Roc
05-8 Realtime PCR Master Mix (Code No. QPK-101, QPK-101T) TOYOBO CO., LTD. Life Science Department OSAKA JAPAN A3313K (2) (2) (3) (3) (4) ABI PRISM 7700 TaqMan (4) Roche LightCycler TM (5) BioFlux LineGene
More informationKyoto University of Art and Design Interdisciplinary Research Center for Performing Arts Annual Report
Kyoto University of Art and Design Interdisciplinary Research Center for Performing Arts Annual Report Vol.1 ANNUAL REPORT URL hp://www.k-pac.org/kyoten/ hp://www.kpac.org/kyoten/en/ / 201432930 13 1320
More information第84回日本遺伝学会-抄録集.indd
A S1 9 24 14 00 17 00 Epigenomic regulation of cell fate determination and homeostasis Organizers: (National Institute of GeneticsKyushu University 14 00 S1-1 1 RIKEN BioResource Center 2 Graduate School
More information08サーベイ部会報告書v1117
CRBSI20012003 CAUTI20042005 2006 VAP VAP CRBSICAUTI X 2006 pilot study 2007 2008 VAP VAP VAP VAP VAP ICN VAP VAP VAP VAP VAP. VAP 2006 VAP 8 2007 2007 42 VAP 2007 2007 VAP 9 2004 NNIS 2007 2008. VAP 2007
More information(2) (2) (3) (3) (5) ABI PRISM 7700 (5) Roche LightCycler TM (7) BioFlux LineGene (9) 1 RT-PCR (10) (12) (13) F. Hoffmann-La Roche Ltd. Roche Molecular
05-8 SYBR Green Realtime PCR Master Mix (Code No. QPK-201, QPK-201T) TOYOBO CO., LTD. Life Science Department OSAKA JAPAN A3314K (2) (2) (3) (3) (5) ABI PRISM 7700 (5) Roche LightCycler TM (7) BioFlux
More informationDocuPrint C5450 ユーザーズガイド
1 2 3 4 5 6 7 8 1 10 1 11 1 12 1 13 1 14 1 15 1 16 17 1 1 18 1 19 1 20 1 21 1 22 1 23 1 24 1 25 1 26 27 1 1 28 1 29 1 30 1 31 1 2 12 13 3 2 10 11 4 9 8 7 6 5 34 24 23 14 15 22 21 20 16 19 18 17 2 35
More information表紙4_1/山道 小川内 小川内 芦塚
1 2008.1Vol.23 2008.1Vol.23 2 2008.1Vol.23 3 2008.1Vol.23 4 5 2008.1Vol.23 2008.1Vol.23 6 7 2008.1Vol.23 2008.1Vol.23 8 9 2008.1Vol.23 10 2008.1Vol.23 11 2008.1Vol.23 12 2008.1Vol.23 Center 13 2008.1Vol.23
More information< > Introduction to Basic Physical Chemistry 1,2 2 [ advanced [ [ [ [ [ KULASIS
< > Introduction to Basic Organic Chemistry 1,2 [ 2 [ 10 11 12 13 14 15 [ [ [ [ KULASIS < > Introduction to Basic Physical Chemistry 1,2 2 [ advanced [ 11 12 14 15 [ [ [ [ KULASIS < > Introduction to Basic
More informationエイズ抄録_修正済1027.idd
Uenishi Rie Biochemistry Laboratory, Institute of Plant Breeding, University of the Philippines Los Banos Experimental Retrovirology Section HIV and AIDS Malignancy Branch, National Cancer Institute,
More informationHIV事件に関する最終報告書
1 2 3 4 5 6 7 AABBAmerican Association of Blood Banks ABRAAmerican Blood Resources Association AIDSAcquired Immune Deficiency Syndrome ARVAIDS-related Virus ATLAdult T-cell Leukemia ATLVAdult T-cell Leukemia
More informationsteponeplus_bro_f-0912.indd
StepOnePlus /StepOne PCR PCR PCR StepOnePlus StepOne PCR PCR Features At A Glance StepOne StepOnePlus / 48 96 FAM /SYBR Green dyes VIC /JOE dyes ROX dyes 1. NED /TAMRA dyes VeriFlex Block StepOnePlus StepOne
More information< > Introduction to Basic Physical Chemistry 1,2 2 [ advanced [ [ [ [ [ KULASIS
< > Introduction to Basic Organic Chemistry 1,2 [ 2 [ 10 11 12 13 14 15 [ [ [ [ KULASIS < > Introduction to Basic Physical Chemistry 1,2 2 [ advanced [ 11 12 14 15 [ [ [ [ KULASIS < > Introduction to Basic
More information0.45m1.00m 1.00m 1.00m 0.33m 0.33m 0.33m 0.45m 1.00m 2
24 11 10 24 12 10 30 1 0.45m1.00m 1.00m 1.00m 0.33m 0.33m 0.33m 0.45m 1.00m 2 23% 29% 71% 67% 6% 4% n=1525 n=1137 6% +6% -4% -2% 21% 30% 5% 35% 6% 6% 11% 40% 37% 36 172 166 371 213 226 177 54 382 704 216
More information10 117 5 1 121841 4 15 12 7 27 12 6 31856 8 21 1983-2 - 321899 12 21656 2 45 9 2 131816 4 91812 11 20 1887 461971 11 3 2 161703 11 13 98 3 16201700-3 - 2 35 6 7 8 9 12 13 12 481973 12 2 571982 161703 11
More informationP07-08
CLUSTER REPORT2010 http://www.noastec.jp Contents 4 3 2 1 01 02 03 04 05 06 07 12 13 16 17 18 3. 1. 2. 1 4 2 5 3 6 !? 1 2 Step.2 Step.3 Step.4 15,396 19,322 24,608 Step.1 1,051 575 27 27 145 118 476 331
More information....
2030 2 Vol. 22 No. 32000 1/2 EE F FAF 60E 1970 40 25FIP 1995 503cx 60 10M5 Vol. 22 No. 32000 3 carpal tunnel syndrome entrapment neuropathy cm 4 Vol. 22 No. 32000 5 Vol. 22 No. 32000 10 2- microglobulin
More information90 27 1 29 ( ) 27 4 26 ( ) 27 4 29 ( ) 4 27 3 30 ( ) 1 30 4 27 4 8 ( ) 16 ( ) 9 P2 3 301 27 4 14 ( ) 15 ( ) 9 5 27 4 21 ( ) 4 27 4 21 ( ) 8 30 5 27 4 23 ( ) 5 10 11 12 13 4 3 4 14 27 4 23 ( 27 4 25 ( )
More informationuntitled
( ) 200133 3 3 3 3, 7 347 57 10 i ii iii -1- -2- -3- -4- 90011001700mm -5- 4.2 1991 73.5 44.4 7.4 10.5 10.5 7.4 W 3 H 2.25 H 2.25 7.4 51.8 140.6 88.8 268.8m 5,037.9m 2 2mm 16cm916cm 10.5 W 3 H 2.25 62.8
More informationMicrosoft Word - H18年度生命工学報告書 Astro ver.3
1. Rotavirus Norovirus Adenovirus Astrovirus Sapovirus 5 1) Human Astrovirus HastV 1975 Madeley Cosgrove EM RNA 30nm 5 6 Fig. 1 2) HastV 8 3 5 HastV ELISA Enzyme-Linked ImmunoSorbent Assay RIA Radio immunoassay
More information(2) (3) (3) (4) (5) ABI PRISM 7700 (5) Roche LightCycler TM (7) BioFlux LineGene (9) (10) (12) F. Hoffmann-La Roche Ltd. Roche Molecular Systems Inc.
06-08 SYBR Green Realtime PCR Master Mix -Plus- (Code No. QPK-211, 211T) TOYOBO CO., LTD. Life Science Department OSAKA JAPAN (2) (3) (3) (4) (5) ABI PRISM 7700 (5) Roche LightCycler TM (7) BioFlux LineGene
More informationResearch 2 Vol.81, No.22013
2 5 8 12 4 16 14,15 15 17 17 18 19 20 21 22 22 23 24 26 7 11 14 25 29 30 31 27 27 28 32 16 29 31 1 Research 2 Vol.81, No.22013 Vol.81, No.22013 3 P r o d u c t s 4 Vol.81, No.22013 Research Vol.81, No.22013
More information一休デイサービスセンター
2770105472 2770105472 2776300135 2776300135 - - 072-274-7219 072-204-7319 http://www.19day.jp/ 072-274-7219 072-204-7319 http://www.19day.jp/ 2007 11 1 45 2007 11 1 45 11 12 4km 10 11 -2- 3-3 - 4 - 5 11
More informationC 1) 2) 3) 4) 5) 6) 7) 8) 9)
130603 (1-3) C 1) 2) 3) 4) 5) 6) 7) 8) 9) C 1) 2) 3) DNA 4) DNA RNA 5) 6) PCR 7) DNA C Cyclops Odlilon Redon, The Cyclops, 1914 WAGR www.wagr.org WAGR www.wagr.org Cell 126, 663-676, 2006 Wikipedia
More informationuntitled
---------- - 1 - ----- 1 Q1 5 Q2 5 Q3 5 Q4 6 Q5 6 Q6 7 Q7 7 Q8 7 Q9 8 Q10 : 8 10 Q1 10 Q2 11 Q3 11 12 Q4 12 Q5 HBs HBc _12 Q6 HBe 12 Q7 13 Q8 NAT 15 Q9 15 Q10 15 Q11 HBs 16 Q12 HBV DNA 16 Q13 17-2 - Q14
More information(2009) 1... / 1 ( ) / 1 ( ) / 1 ( ), 2 ( )
212009................................................ 2............................................ 115 (2009) 1... / 1 ( )........................................... 4 2... / 1 ( )......................................
More informationp.01....
40 2 Vol. 22 No. 82000 10 10 12 21 Vol. 22 No. 82000 3 1858 13 1842 1862 1868 1871 1872 1836 4 Vol. 22 No. 82000 5 Vol. 22 No. 82000 1871 1869 10 12 187514 ü 6 Vol. 22 No. 82000 600 1,200 1020 100 18431883
More informationDynalTransplantDiagnostic.indd
2011 1 SeCore HLA SBT 1 2 AllSet + Gold SSP HLA 7 3 SSP UniTray HLA 11 4 27 5 32 ii 1 SeCore HLA SBT SeCore 2 SeCore HLA SBT SeCore 3 SeCore 4 HLA-I 5 HLA-II 5 utype 5 GSSP 6 1 SeCore HLA SBT Sequencing
More information19 8 1970 20 10 4 1
19 8 1970 20 10 4 1 IgE 1960 % 1970 20%, 1990 40% 1998 70% 20 IgE 21 90% IgE IgE (%) 70 60 50 40 30 20 10 0 1970 1975 1980 1985 1990 1995 2000 2005 1. 2005 10 2 30 IgE 2. 3 1. B IgE T IgE IgE IgE 2 T IgE
More information表紙PDF作成用/PDF表紙作成用
2010 Vol.52 No.2! ! Jpn J School Health Jpn J School Health Jpn J School Health! Jpn J School Health Aichi University of Education Nagoya University "! Jpn J School Health! Graduate School of Public Health
More informationHistory I COE
2008 108-8641 5-9-1 TEL 03-5791-6334FAX 03-5791-6335 e-mailgakufu@lisci.kitasato-u.ac.jp 228-8555 1-15-1 TEL 042-778-9760FAX 042-778-9761 e-mailnyushi@kitasato-u.ac.jp URL http://www.kitasato-u.ac.jp/lisci/index.html
More informationDNA 型鑑定による個人識別の歴史・現状・課題
DNA DNA DNA DNA DNA DNA PCR Polymerase Chain Reaction DNA VNTR STR SNPs Single Nucleotide Polymorphism DNA DNA DNA biology metrics DNA 1 2 DNA, 2005, p.194. 2006. 7 19 1832 3 4 19 5 1853 1878 6 1879 11
More information表紙PDF作成用/PDF表紙作成用
2008 Vol.50 No.1 Jpn J School Health Jpn J School Health Jpn J School Health Jpn J School Health Hosen Junior High School, Okayama City Notre Dame Seishin University Graduate School Jpn J School Health
More informationMicrosoft Word - ゴールドコーストマラソン2014.docx
2014 2014 7 3 7 14:25 16:20 22:25 6:25 10:55 19:00 22:55 0:35 42.195Km 7,300km 537,844 2013 6 30 6 2 1 Dr. 1 20 10 Q1 Q1 8m 2 7 4 15 J B H..S 45 30 7 20 49 20 15 3 45 4 3 50 28 35 km 40km 4 4 6 15km 20km
More informationuntitled
~ ~ ~ ~ ~ 22 14 10 50cm 2124 15 21 29.5 11, 12 12 20 4040 10 60 60 10 20 20 11 ç ç çç 6070 ç ç çç p. ç çç 4.5cm2.5cm 25 http://www.crdc.gifu-u.ac.jp/edsoftol/water/
More informationuntitled
38 2013 ITAA in OSAKA 2013 81517 38 2013 ITAA in OSAKA 2013 815 17 38 2013 ITAA in OSAKA P01 1001 1002 1004 1005 1010 10F 12F 830 900 8 15 8 16 8 17 830 900 915 1000 1100 1200 10001145 1 10001300 9451200
More informationMHC 2013; 20 ( 2 QC QC DNA-QC 3. QCWS 集会参加および参加証明書発行 QCWS QCWS QCWS 解析方法 DNA-QC Luminex SSO SSO SSP SBT QC FlowPRA Lab Screen WAK Flow ICFA 4 HL
Major Histocompatibility Complex 2013; 20 (: 13 16 QCWS # 1. ワークショップの経過 24 1 QCWS HP QCWS 24 2 57 DNA-QC 53 QC 38 1 20 QCWS DNA-QC QC 4 QCWS 4 4 4 16 QCWS 5 21 57 DNA-QC 53 QC 37 5 6 7 HP 8 25 HP 2. QCWS
More informationŁ½’¬24flNfix+3mm-‡½‡¹724
571 0.0 31,583 2.0 139,335 8.9 310,727 19.7 1,576,352 100.0 820 0.1 160,247 10.2 38,5012.4 5,7830.4 9,5020.6 41,7592.7 77,8174.9 46,425 2.9 381,410 24.2 1,576,352 100.0 219,332 13.9 132,444 8.4 173,450
More informationuntitled
6 ( ). 1.. 1. 2. 3. 4. 5. ( ) 6. 7. 8. . 1. 1) 1 (12 3 ) 2 2) 3) ( ) ( ) 4) 2 () 2 2 3 5) ( ) R-Book ATLAS () 8 12 7 18 14 16 10 21 14 23 16 18 16 18 12 25 4 14 21 1 4 2 3 4 4 1 2 7 5 1 2 5 7 9 1 1 5 5
More informationYK170 17β-Estradiol EIA キット
YK170 17 - Estradiol EIA FOR RESEARCH LABORATORY USE ONLY 418-0011 2480-1 FAX: 0544-22-2770 TEL: 0544-22-2771 Website: www.yanaihara.co.jp E-mail: ask@yanaihara.co.jp . 2. 3. 4. 5 6. 7. 8 10. 11. 11 1
More informationエクラー軟膏0.3%、エクラークリーム0.3%、エクラーローション0.3%_IF
2005 1 872646 IF 1998 9 1g 3mg(0.3%) Deprodone Propionate 2003227 200374 1997415( ) 1998316( ) F A X 2003 7 1992 3 17 1997 10 9 1992 5 22 1997 12 19 IF 2005 4 IF 1. MR 63 2 IF 10 3 IF 2. IF IF IF 3. IF
More informationBTI T90% Tave Tave Tave T90% 48 JICE REPORT vol.20/ 11.12
JICE REPORT vol.20/ 11.12 47 BTI T90% Tave Tave Tave T90% 48 JICE REPORT vol.20/ 11.12 TB Σ Tt Ts N TB Tt Ts N JICE REPORT vol.20/ 11.12 49 50 JICE REPORT vol.20/ 11.12 JICE REPORT vol.20/ 11.12 51 52
More informationVol.9No.22012
6 21 2 21 8 7 118 Vol.9No.22012 6 2 3 1 10 10 1 13 1 13 1320 1956 1961 1977 21 8 1979 1981 1982 2011 2003 20062011 Vol.9No.22012 119 1 23 8 21 1 1 24 20 22 18 8 120 Vol.9No.22012 2 9 1953 2 1979 2 2 1982
More informationQ E Q T a k Q Q Q T Q =
i 415 q q q q Q E Q T a k Q Q Q T Q = 10 30 j 19 25 22 E 23 R 9 i i V 25 60 1 20 1 18 59R1416R30 3018 1211931 30025R 10T1T 425R 11 50 101233 162 633315 22E1011 10T q 26T10T 12 3030 12 12 24 100 1E20 62
More information17-05 THUNDERBIRD SYBR qpcr Mix (Code No. QPS-201, QPS-201T) TOYOBO CO., LTD. Life Science Department OSAKA JAPAN A4196K
17-05 THUNDERBIRD SYBR qpcr Mix (Code No. QPS-201, QPS-201T) TOYOBO CO., LTD. Life Science Department OSAKA JAPAN A4196K - 18 - [1] 1 [2] 2 [3] 3 [4] 5 [5] : RNA cdna 13 [6] 14 [7] 17 LightCycler TM Idaho
More information1 1 1 2 2 3 3 4 5 6 6 7 8 8 8 9 10 10 14 16 17 17 18 18 18 23 27 27 27 28 29 29 30 30 31 32 32 33 34 34 35 36 37 38 38
2007 2006 11 29 1 1 1 2 2 3 3 4 5 6 6 7 8 8 8 9 10 10 14 16 17 17 18 18 18 23 27 27 27 28 29 29 30 30 31 32 32 33 34 34 35 36 37 38 38 40 40 40 11 41 41 42 42 43 43 44 45 46 46 47 47 49 50 51 51 52 53
More information日本消化器外科学会雑誌第29巻第9号
Table 1 Oligonucleotide primers used for RT-PCR and internal probes used for Southern blot hybridization Cytokine Primer Sequence (5'-3') 5' 3' Internal probe s' 3' Internal probe 5' 3' Internal probe
More informationuntitled
69 * 984 994 7 4 9,5 5,6 3% 8 8 9 4 3 4 * yzuoy@r.o. fuw@gs.goy-u.. sho@r.o. twt@.gu.. 69 5-994 994 3 7-7 994 3 75% 5% - 6 5 9 9 994 7-994 69 994 994 46%,34 5% 99 4% 3% 7 3% 3-993 8 97 8 5 4 398 % 4% 4%
More information日本組織適合性学会誌第23巻2号
Major Histocompatibility Complex 2016; 23 (2): 115 122 HLA 1 1) 1) HLA MHC 1900 HLA HLA キーワード : HLA HLA HLA HLA 2 HLA HLA HLA 3 1 1 HLA HLA 図 1 2016 6 30 2016 8 2 105 0013 1 10 14 3 5 TEL: 03 5776 0048
More information11月/庵原俊昭
Shigetaka KATOW 1 1 2 2 3 1 1 1960 5 10 1 8 1 1 1 6 Irtyersenu BC600 2009 1 9,000 2 2008 2 2009 1 AD1 50 DNA 0100-0006 - - RIKEN Center of Research Network for Infectious Diseases (Yurakucho-Denki Bldg.
More informationsteponeplus_bro_f-1124.indd
PCR StepOnePlus /StepOne PCR PCR PCR StepOnePlus StepOne PCR PCR Features At A Glance StepOne StepOnePlus / 48 96 FAM /SYBR Green dyes VIC /JOE dyes ROX dyes 1. NED /TAMRA dyes VeriFlex Block StepOnePlus
More information-1 - -2 - -3 - -4 - -5 - -6 - -7 - -8 - -9 - - 10 - -11 - - 12 - - 13 - - 14 - - 15 - - 16 - - 17 - - 18 - - 19 - - 20 - - 21 - - 22 - - 23 - - 24 - - 25 - - 26 - - 27 - - 28 - - 29 - - 30 - - 31 - - 32
More information函館市_絵で見てわかる
70 75 26 2 27 1 2 3 4 5 6 7 8 9 4 6 6 6 8 10 10 10 10 12 21 21 22 26 28 30 32 34 36 2 3 70 75 701 28 75 6575 7075 28 75 3 4 5 75 65 26 28 75 65 75 1 1 70 7075 2 2 2 1 260 90 210 18 9012 160 18 100 183
More informationッ ー ー ー() () 2.5 () () 21 1) -1 2) -2 10 m 5 7 23 6 1)2) 3) -1-2 H23.4.25 -15-20 4 75 5 1) -1 (5) (3) (3) (2) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) 1) ( 23 6 8 ) 2) 22 3)
More information(1) 5 (2) VNTR IS6110RFLP, VNTR35loci JATA(12) JATA(12) MIRU(12) Supply(15) (3) INH inha 22 (4) 5 5 INH RFP 95% 90% 90% 11 (5) 5
(1) 5 (2) VNTR IS6110RFLP, VNTR35loci JATA(12) JATA(12) MIRU(12) Supply(15) (3) INH inha 22 (4) 5 5 INH RFP 95% 90% 90% 11 (5) 5 (6) 30-50 2006 MDR 97 XDR 43.3 15-optimized MIRU VNTR 17 gralnulysin 15k
More information日本でエイズが増え続ける原因は何か
2005 12 22 12022050 1 2 HIV AIDS 3 3.1 HIV 3.2 3.3 1 2 3.4 1 2 3 3.5 3.6 3.7 4 4.1 HIV AIDS 4.2 4.3 4.4 4.5 4.6 5 5.1 5.2 6 URL 1 1981 5 24 5 4,000 UNAIDS 2005 490 AIDS 310 110 140 2 1.5 HIV 2004 HIV 6,527
More information2
1 vol.677 2 information 3 information 4 http://www.keiba.go.jp/ 5 research 6 7 8 9 infomation http://www.shimane.info.maff.go.jp/ 10 11 information http://www.shimane.info.maff.go.jp/ 12 13 information
More information12-7 12-7 12-7 12-7 12-8 12-10 12-10 12-10 12-11 12-12 12-12 12-14 12-15 12-17 12-18 10 12-19 12-20 12-20 12-21 12-22 12-22 12-23 12-25 12-26 12-26 12-29 12-30 12-30 12-31 12-33 12-34 12-3 12-35 12-36
More informationuntitled
HCV 150 HCV 13 3 13 4 13 8 14 2 14 2 14 8 15 3 15 8 17 3 7 8 18 3 ----- i Q1 1 Q2 1 Q3 1 Q4 2 Q5 3 Q6 3 Q7 3 Q8 4 Q9 4 Q10 : 5 6 Q1 6 Q2 7 Q3 7 8 Q4 8 Q5HCV 8 Q6HCV 9 Q7HCV 9 Q8NAT 10 Q9 10 Q10 11 Q11
More informationInfinium BeadChip COGS BeadChip 4 * iselect 3 SNP 25 1 SNP NGS Sequencing by Synthesis SBS HiSeq MiSeq WGS 1 RNA-Seq ChIP-Seq 1 1 * icogs BCAC OCAC PR
Infinium BeadChip COGS BeadChip 4 * iselect 3 SNP 25 1 SNP NGS Sequencing by SynthesisSBSHiSeq MiSeq WGS 1 RNA-Seq ChIP-Seq 1 1 * icogs BCACOCAC PRACTICALBRCA1/2 CIMBA www.illuminakk.co.jp DNA CE DNA DNA
More information12331514 20131126 1 2 3 1 2 2 52495 4 1122 1 2 2 2 3 45 1 2 1 3 2 4 Z 8305 1962 8 4 2 1 2 2 35 3 12 1 2 32 4418 4 1 5 323 6 11111 332 5 342 6 1 23 4 2 3 7 3 2 3 25175 19132 8 2 1 1 2 3 4 5 6 7 2 1 2 3
More information1 1 1 11 25 2 28 2 2 6 10 8 30 4 26 1 38 5 1 2 25 57ha 25 3 24ha 3 4 83km2 15cm 5 8ha 30km2 8ha 30km2 4 14
3 9 11 25 1 2 2 3 3 6 7 1 2 4 2 1 1 1 11 25 2 28 2 2 6 10 8 30 4 26 1 38 5 1 2 25 57ha 25 3 24ha 3 4 83km2 15cm 5 8ha 30km2 8ha 30km2 4 14 60 m3 60 m3 4 1 11 26 30 2 3 15 50 2 1 4 7 110 2 4 21 180 1 38
More information座談会/2009
6 2008 10 3 9 2008 2 9 Asian-African Research Network 4 A preliminary experiment of Japan over these four years05 08 1900 2000 50 3 50 3 1969 Surgeon General William T. Stewart 2003 SARS SARS 2003 2 M
More information-1-
-1- -2 - 2000 1 1 5-3 - 21 10 2-4 - 5-5 - -6 - -7- -8 - 21 2000 21-9- IT in silico 10-10 - -11 - 20 21 1993 ICH - 12 - 2007 4 1 NIHThe National Institutes of Health2004 NIH NIH 2006 UK Clinical Research
More information尿閉.PDF
1 JUN.2006 Vol.15 No.1 M2,M3 2 1 Vol.15,No1,2006 2 3 T10-L2 10-2 S2-4 2-4 m1m5 M1M5 5 M M3 5% M3 M2 Vol.15,No1,2006 4 5 6 9 Vol.15,No1,2006 6 7 a. 5 1 100 30 40% b. Vol.15,No1,2006 8 a a c. 2 2 2 d. 8
More informationsteponeplus_bro_f-0210.indd
StepOnePlus / StepOne PCR PCR Applied Biosystems StepOnePlus StepOne PCR 1 Features At A Glance StepOne StepOnePlus / 48 96 FAM/SYBR Green dyes VIC/JOE dyes ROX dyes NED/TAMRA dyes 1. VeriFlex Block StepOnePlus
More information(1) (2) (3) (4) (5) (6) (7) 4 (8) (9) () LAN 1 2 3 ( ) () () () 30 20 5 5 450 450 5 5 30 10 20 15 36 30 6 6 450 450 6 6 36 8 30 14 50 35 20 20 450 450 20 20 50 8 35 14 100 70 20 20 450 450
More informationuntitled
PCRM-PCR PCR MPCR Dualreal PCR PCR (M-PCR) PCR (M-PCR) Q & A PCR DNA 50 2030 DNA PCR 1 PCR (MPCR) MBI PCR 1 MPCR 1 MPCR DNA 1 PCR 510 DNA (US patent 5, 582, 989) 1 DNA ( 1) MPCR GC MBI MPCR PCR DNA 2 MBI
More informationMicrosoft Word - Documento2
? 3 2 ... 19 20 20 2 1 1 20 40 20 2 9 20 20 2 40 : http://www.hirahidenobu.com/scw/entry 平 秀 信 : 250 400 2 4 58CD4 CD1: 2 2 CD2 URL CD3: CD4: CD CD4... 250 200 250 http://www.hirahidenobu.com/scw/entry
More information3 DI 29 7 1 5 6 575 11 751, 13 1,1,25 6 1,251,5 2 1,51,75 1,752, 1 2,2,25 2,252,5 2,53, 3,3,5 3,5 5 1 15 2 25 3 5 6 575 12 751, 21 1,1,25 27 1,251,5 9 1,51,75 1,752, 1 2,2,25 2 2,252,5 2,53, 2 3,3,5
More information